US Stock MarketDetailed Quotes

APVO Aptevo Therapeutics

Watchlist
  • 0.750
  • +0.038+5.26%
Trading Jun 3 12:13 ET
3.06MMarket Cap-8P/E (TTM)

Aptevo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aptevo Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-9.95

-157.25%
Analyst Rating

Buy

May 31, 2024

Aptevo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 3.425M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 3.425M--

Unlock Free Earnings Estimates

Aptevo Therapeutics Earnings Reports

  • Aptevo Therapeutics | 10-Q: Quarterly report

    May 8 08:33 ET

  • Aptevo Therapeutics | 10-K: Annual report

    Mar 5 08:32 ET

  • Aptevo Therapeutics: Q3 2023 Earnings Report

    Nov 14, 2023 08:30 ET

  • Aptevo Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 08:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg